-
Press Release
2018/01/11
Abnova developed and submitted RoHS compatible CytoQuest™ CR System for SGS and CE-IVD certification
-
Press Release
2017/09/11
Abnova Enters Third-Party Diagnostic Market in China
-
Press Release
2017/08/22
Abnova Gains Precision Medicine Momentum
-
Press Release
2017/07/21
Abnova (Dongguan) Diagnostics’ CytoQuest™ CR System Gains Class I In Vvitro Diagnostics EMC & Safety CFDA Approval in China
-
Press Release
2017/04/07
Wealth Magazine (Taiwan), Issue 526, Pages 152-155, “Abnova’s Biotechnology Revolution”
-
Press Release
2017/04/03
Abnova Announces the Opening of Abnova Diagnostics (Japan) Office and Clinical Laboratory for Precision Medicine Market in Japan
-
Press Release
2017/01/12
Abnova Signed Strategic Alliance Agreement with HangZhou Watson Biotech to Catapult the Circulating Tumor Cell Precision Market in China
-
Press Release
2016/05/12
Abnova Personal A1c Diabetes HbA1c Rapid Test Gains CFDA In Vitro Diagnostics Approval and Marketing in China
-
Press Release
2016/04/06
Abnova Gains Worldwide Exclusive License to CSV Monoclonal Antibody from MD Anderson Cancer Center for Detection of Cancer-Specific Circulating Tumor Cells
-
Press Release
2016/03/07
Abnova (Dongguan) Diagnostics Aims for Precision Medicine Market in China